The Clorox Company (CLX) Stock: Price, Forecast & Analyst Target
The Clorox Company (CLX) — MoonshotScore 60/100 (Fair band), calculated Nov 18, 2026. Price $104.90 (-3.22%), as of the Nov 19, 2026 trading session; market cap $12.7B. Expected results Feb 2, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 69.02× (cash as of Sep 30, 2026) · expected results Feb 2, 2027
The Clorox Company · CLX · NYSE · Consumer Defensive · Household & Personal Products
Research dated 2026-09-13: Clorox sells branded cleaning, household, food, personal-care, filtration and wellness products through retail, professional and international channels. Its case rests on whether brand investment can revive sales and margins strongly enough to support cash generation while debt remains heavy.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · The Clorox Company (CLX)
FairWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality, but a strained balance sheet and an expensive valuation; the market is already moving on it. Business Quality: Solid; Financial Safety: Strained; Valuation: Rich; Growth Durability: Flat; Momentum: Rising.
Enterprise value relative to free cash flow is the main valuation drag relative to sector peers.
- quarterly revenue $1.43B (Q1 FY2026, quarter ended Sep 2025)
- EPS beat 0 of the last 4 reports
- expected results Feb 2, 2027
Holding back: a rich price
Helping: business quality, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 58 | Fair | |
| 59 | Fair | |
| 59 | Fair | |
| 59 | Fair | |
| 60 | Fair | |
| 60 | Fair |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $104.90 | |
| Change on the day | -3.22% | |
| 52-week range | $79.12–$128.90 | |
| Market capitalisation | $12.7B | — |
| Price / earnings (trailing) | 19.19 | |
| Shares traded on the day | 2.24M | |
| Beta (volatility vs the S&P 500) | 0.58 | |
| Dividends per share (last 12 months) | $4.98 | |
| Dividend yield (last 12 months) | 4.67% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · below the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings call · management outlook
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
So essentially, our guidance is organic sales growth, excluding the impact of the ERP, is flat to plus 1% for the full year.
Luc Bellet · Statement from
And so we're seeing gross margin compression on average for the full year, but we'll expect to exit the year with much stronger gross margin.
Luc Bellet · Statement from
How to read these dates
A statement's date is the earnings call where it was made, not a deadline. Management expectations and estimated dates can change.
Other perspectives
Council score for The Clorox Company (CLX): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 17, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is The Clorox Company (CLX), and what does it report?
Short answer · as of
Clorox is not merely a bleach or disinfectant company. Its portfolio spans home cleaning, professional sanitation, cat litter, bags and wraps, charcoal, dressings and sauces, natural personal care, water filtration, and supplements, making consumer usage and retailer demand across distinct categories the underlying units of demand.
Research dated 2026-09-13.
Reported revenue is divided among Health and Wellness, Household, Lifestyle and International. Health and Wellness contributes the largest share, while the remaining segments expose Clorox to different purchase occasions, channels and category pressures.
What do the latest results show for The Clorox Company (CLX)?
Short answer · as of
The most recent reported quarter, Q1 FY2026, carried revenue of $1.43B.
Research dated 2026-09-13.
The latest annual results show lower revenue and profit than the prior year. The latest reported quarter also produced weaker sales, gross profit and earnings than the comparable period, despite revenue and adjusted earnings coming in above analyst expectations.
Operating cash flow recovered sharply after turning negative in the preceding quarter, but the sequence remains uneven. Management expects stronger gross margin by the end of the current fiscal year without fully recovering the full-year result, while planned spending on product superiority could support demand at the cost of near-term resources.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $1.91B Sep 30, 2026
- Latest quarter · R&D
- $29.00M Sep 30, 2026
- Latest quarter · SG&A
- $480.00M Sep 30, 2026
- Latest quarter · FMP standardized operating result
- $261.00M Sep 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | $1.91B | $29.00M | $480.00M | $261.00M |
| Jun 30, 2026 | $1.95B | $32.00M | −$235.00M | $1.02B |
| Mar 31, 2026 | $1.67B | $27.00M | $406.00M | $284.00M |
| Dec 31, 2025 | $1.67B | $29.00M | $452.00M | $236.00M |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $1.91B Nov 2, 2026
- Latest report · revenue estimate
- $1.88B Nov 2, 2026
- Latest report · revenue vs estimate
- Above estimate Nov 2, 2026
- Latest report · EPS vs estimate
- Above estimate Nov 2, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Nov 2, 2026 | $1.91B | $1.88B | $1.5500 | $1.0700 |
| Aug 3, 2026 | $1.95B | $1.91B | $1.6600 | $1.6400 |
| Apr 30, 2026 | $1.67B | $1.67B | $1.6400 | $1.5500 |
| Feb 3, 2026 | $1.67B | $1.64B | $1.3900 | $1.4300 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 FY2026 | $1.43B | $80M | $0.65 (diluted) |
| Q2 FY2026 | $1.67B | $157M | $1.29 (diluted) |
| Q3 FY2026 | $1.67B | $187M | $1.54 (diluted) |
| Q4 FY2026 | $1.95B | $163M | $1.33 (diluted) |
What are the financial strengths and risks for The Clorox Company (CLX)?
Short answer
Cash and short-term investments were $184.00M at the Sep 30, 2026 balance-sheet date. Operating cash flow was $143.00M for the quarter ended Sep 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-13.
Clorox remains profitable and generates operating cash, but liquidity offers little protection against its debt load. Cash sits far below total debt, short-term liquidity ratios are below full coverage, and the cash balance ended below where it began across the reported window.
The main financial risk is that weak sales or incomplete gross-margin recovery reduces the cash available for capital spending, dividends and debt service. Recent cash generation and continued dividend payments show that the business still produces distributable cash, yet the volatile quarterly pattern makes sustained conversion more important than any isolated period.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $143.00M Sep 30, 2026
- Previous quarter · operating cash flow
- $330.00M Jun 30, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Sep 30, 2026 | $143.00M | −$38.00M |
| Jun 30, 2026 | $330.00M | −$86.00M |
| Mar 31, 2026 | −$122.00M | −$43.00M |
| Dec 31, 2025 | $311.00M | −$42.00M |
How to read these figures
Amounts are in US dollars. Negative operating cash flow means the business used cash. Capital spending is shown as reported; we do not combine it into a free-cash-flow or runway estimate. The bars share one scale.
What should you watch next at The Clorox Company (CLX)?
Short answer · as of
The next earnings report is expected on Feb 2, 2027.
Research dated 2026-09-13.
Watch whether sales return to growth across the branded portfolio and whether gross profit improves alongside them. A healthier result would combine revenue progress, stronger gross margin and dependable operating cash flow rather than relying on earnings performance alone.
Management has set expectations for stronger cash generation, a better exit gross margin and eventual revenue benefits from current initiatives. The scheduled earnings release should reveal whether those claims are beginning to appear while analyst estimates assume continuing revenue and earnings growth over the following years.
Cash deserves separate attention after its sharp rise and subsequent fall. Stabilization alongside positive operating cash flow would strengthen the financial picture; renewed cash contraction without better sales or margins would increase the weight of the debt burden.
What management is planning
What the records here don't tell us
- The newest quarter held here (Q1 FY2026) was filed Nov 3, 2025 — 12 months ago.
Checked against the records this page reads, on the dates shown above.
How does The Clorox Company compare with its peers?
Short answer
The Clorox Company's score ranks 12th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
Clorox differs from a narrowly focused cleaning-products business because its brands serve household maintenance, pet care, grilling, food, personal care, filtration and wellness demand. That breadth diversifies purchase occasions, but it also means consolidated performance can reflect unrelated category movements.
Its reporting structure makes the mix visible: Health and Wellness is the largest segment, while Household, Lifestyle and International remain substantial contributors. Clorox therefore combines domestic branded staples with professional products and an international portfolio rather than depending on a single product family or sales channel.
| Company | Price | Market value | Score |
|---|---|---|---|
| $133.73 Nov 18, 2026 | $4.28B | 96 5-pillar Nov 18, 2026 | |
| $98.85 Nov 18, 2026 | $78.6B | 93 5-pillar Nov 18, 2026 | |
| $63.36 Nov 19, 2026 | $136B | 88 5-pillar Nov 18, 2026 | |
| $75.87 Nov 19, 2026 | $1.74B | 87 5-pillar Nov 18, 2026 | |
| $113.77 Nov 18, 2026 | $6.73B | 84 5-pillar Nov 18, 2026 | |
| $109.68 Nov 19, 2026 | $25.9B | 82 5-pillar Nov 18, 2026 | |
| $201.34 Nov 19, 2026 | $13.4B | 80 5-pillar Nov 18, 2026 | |
| $107.24 Nov 18, 2026 | $65.8B | 79 5-pillar Nov 18, 2026 | |
| $107.63 Nov 19, 2026 | $17.0B | 66 5-pillar Nov 18, 2026 | |
| $45.83 Nov 19, 2026 | $12.3B | 65 5-pillar Nov 18, 2026 | |
| $101.77 Nov 19, 2026 | $36.9B | 64 5-pillar Nov 18, 2026 | |
| The Clorox Company (CLX) — this page | $104.90 | $12.7B | 60 |
| $62.45 Nov 18, 2026 | $14.4B | 58 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $74.00 – $99.00
- Consensus target
- $88.88
- Median target
- $89.00
Consensus record · Captured .
Measured against a quoted price of $104.90 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Of the newest 500 records, those within the last 180 days, newest dated Nov 4, 2026
- Transactions
- 48
- Identified insiders
- 12
- Purchases
- 1
- Sales
- 0
- Other transactions
- 47
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 84.2% Period end Sep 30, 2026
- Previous quarter · ownership
- 86.5% Prior to period end Sep 30, 2026
- Reporting holders
- 1,027 Period end Sep 30, 2026
- Previous quarter · holders
- 1,110 Prior to period end Sep 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Blackrock, INC. | 8,121,560 |
| Vanguard Capital Management LLC | 7,926,864 |
| State Street Corp | 7,723,356 |
| Invesco Ltd. | 6,294,677 |
| Vanguard Portfolio Management LLC | 5,659,243 |
Tracked investors
Which of the 16 named investors we follow held CLX in their latest 13F filing, and what they did against the filing before it.
| Investor | Manager | 13F quarter | Portfolio weight | Value | Last quarter |
|---|---|---|---|---|---|
| Fundsmith | Terry Smith | Q3 2026 | 0% | $0 | Sold out (was $25.89M) |
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Holder snapshot as of Sep 30, 2026. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about The Clorox Company (CLX)?
- A $1,200,000 Portfolio in Clorox, Kimco Realty and Eversource Pays $54,576 a Year in Dividends. Here’s What Happens if One Cuts
- Should You Buy Clorox Stock At This Price?
- Clorox Just Declared Another Dividend, but Its $5 Payout Faces a Debt Test
- Clorox Declares Regular Quarterly Dividend of $1.25 Per Share
What Investors Ask About The Clorox Company (CLX) — Consumer Defensive
Research dated 2026-09-13; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
Is Clorox mainly a bleach and disinfectant company?
Cleaning is central, but Clorox also sells cat litter, food-storage products, charcoal, dressings, personal care, filtration products and supplements. Its results reflect this broader collection of branded household and wellness categories.
Why does Health and Wellness matter so much to Clorox?
Health and Wellness is Clorox’s largest reported segment and includes consumer cleaning, professional sanitation and supplements. Its scale means weakness or recovery there can materially shape consolidated sales.
Can Clorox support its dividend while carrying heavy debt?
Clorox is profitable and continues to generate operating cash, but cash is small relative to debt and quarterly conversion has been uneven. Dividend durability therefore depends on sustained cash generation rather than the balance-sheet cash reserve.
What would confirm Clorox gross-margin recovery?
Confirmation would require gross profit to strengthen across upcoming results while revenue stabilizes and operating cash flow remains positive. Management expects a stronger exit margin but does not expect full-year recovery, making the progression more informative than an isolated quarter.
What is the CLX stock price today?
The last price recorded for The Clorox Company (CLX), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the CLX price target?
The analyst consensus price target for The Clorox Company (CLX), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 82 figures on this page — 2 from SEC filings and earnings calls, 71 from Financial Modeling Prep (FMP), 2 with no recorded source, 5 computed by us, formula shown in the register and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources (as of 2026-09-13), by section of the research
ETFs that hold CLX
Funds in our ETF coverage that list CLX among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.